Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys

Overview

Journal Clin Diabetes

Specialty Endocrinology

Date 2018 Feb 1

PMID 29382979

Citations 40

Authors

Robert Engler

Timothy L Routh

Joseph Y Lucisano

Affiliations

Soon will be listed here.

Abstract

A patient-centered approach to device design can provide important advantages in optimizing diabetes care technology for broadened adoption and improved adherence. Results from two surveys of people with diabetes and the parents of children with diabetes ( = 1,348) regarding continuous glucose monitoring (CGM) devices reveal the importance of the concept of "user burden" in patients' and caregivers' evaluations of the acceptability of available devices. Survey respondents' strongly favorable reactions to a proposed 1-year, fully implanted CGM device with no skin-attached components further confirm that minimizing system obtrusiveness will likely be of significant value in reducing hurdles to CGM device use and adherence.

Citing Articles

A Prospective Pilot Study Demonstrating Noninvasive Calibration-Free Glucose Measurement.

Rothenbuhler M, Lizoain A, Rebeaud F, Perotte A, Stoffel M, DeVries J J Diabetes Sci Technol. 2025; :19322968251313811.

PMID: 39881452 PMC: 11780617. DOI: 10.1177/19322968251313811.

Cutaneous Adverse Effects From Diabetes Devices in Pediatric Patients With Type 1 Diabetes Mellitus: Systematic Review.

Podwojniak A, Flemming J, J Tan I, Ghani H, Neubauer Z, Jones A JMIR Dermatol. 2024; 7:e59824.

PMID: 39622650 PMC: 11587996. DOI: 10.2196/59824.

Improving Continuous Glucose Monitoring Use in Emerging Adults With Type 1 Diabetes.

Malik F, Perez S, Lowry S, Weaver K, Hirsch I, Pihoker C Clin Diabetes. 2024; 42(4):570-573.

PMID: 39429462 PMC: 11486856. DOI: 10.2337/cd23-0104.

Expansion of Medicaid Coverage of Continuous Glucose Monitor Reduces Health Disparity in Children and Young Adults With Type 1 Diabetes.

Miyazaki B, Zeier T, Barber R, Espinoza J, Chao L J Diabetes Sci Technol. 2024; 19322968241287217.

PMID: 39397768 PMC: 11571635. DOI: 10.1177/19322968241287217.

Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010-2013 to 2016-2019.

Lacy M, Lee K, Atac O, Heier K, Fowlkes J, Kucharska-Newton A Clin Diabetes. 2024; 42(3):388-397.

PMID: 39015169 PMC: 11247039. DOI: 10.2337/cd23-0051.

References

Klonoff D . Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005; 28(5):1231-9. DOI: 10.2337/diacare.28.5.1231. View

Miller K, Foster N, Beck R, Bergenstal R, DuBose S, DiMeglio L . Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015; 38(6):971-8. DOI: 10.2337/dc15-0078. View

Young-Hyman D, De Groot M, Hill-Briggs F, Gonzalez J, Hood K, Peyrot M . Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016; 39(12):2126-2140. PMC: 5127231. DOI: 10.2337/dc16-2053. View

Vigersky R . The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus. J Diabetes Sci Technol. 2015; 9(2):320-30. PMC: 4604582. DOI: 10.1177/1932296814565661. View

Tamborlane W, Beck R, Bode B, Buckingham B, Peter Chase H, Clemons R . Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359(14):1464-76. DOI: 10.1056/NEJMoa0805017. View

New J, Ajjan R, Pfeiffer A, Freckmann G . Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med. 2015; 32(5):609-17. DOI: 10.1111/dme.12713. View

. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care. 2009; 33(1):17-22. PMC: 2797966. DOI: 10.2337/dc09-1502. View

Beck R, Buckingham B, Miller K, Wolpert H, Xing D, Block J . Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009; 32(11):1947-53. PMC: 2768196. DOI: 10.2337/dc09-0889. View

Wong J, Foster N, Maahs D, Raghinaru D, Bergenstal R, Ahmann A . Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014; 37(10):2702-9. PMC: 4392936. DOI: 10.2337/dc14-0303. View

10.

Mariani H, Layden B, Aleppo G . Continuous Glucose Monitoring: A Perspective on Its Past, Present, and Future Applications for Diabetes Management. Clin Diabetes. 2017; 35(1):60-65. PMC: 5241770. DOI: 10.2337/cd16-0008. View

11.

Gonder-Frederick L, Shepard J, Grabman J, Ritterband L . Psychology, technology, and diabetes management. Am Psychol. 2016; 71(7):577-589. DOI: 10.1037/a0040383. View

12.

Nathan D . The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2013; 37(1):9-16. PMC: 3867999. DOI: 10.2337/dc13-2112. View

13.

Chamberlain J, Dopita D, Gilgen E, Neuman A . Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year. J Diabetes Sci Technol. 2015; 10(2):383-8. PMC: 4773957. DOI: 10.1177/1932296815604633. View

14.

Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J . Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011; 34(4):795-800. PMC: 3064030. DOI: 10.2337/dc10-1989. View

15.

Tanenbaum M, Hanes S, Miller K, Naranjo D, Bensen R, Hood K . Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets. Diabetes Care. 2016; 40(2):181-187. PMC: 5864141. DOI: 10.2337/dc16-1536. View

16.

Foster N, Miller K, Tamborlane W, Bergenstal R, Beck R . Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections. Diabetes Care. 2016; 39(6):e81-2. PMC: 5317243. DOI: 10.2337/dc16-0207. View

17.

. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Care. 2016; 39(5):686-93. PMC: 4839174. DOI: 10.2337/dc15-1990. View

18.

Rodbard D . Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technol Ther. 2016; 18 Suppl 2:S3-S13. PMC: 4717493. DOI: 10.1089/dia.2015.0417. View

19.

Anhalt H . Limitations of Continuous Glucose Monitor Usage. Diabetes Technol Ther. 2016; 18(3):115-7. DOI: 10.1089/dia.2016.0011. View

20.

Battelino T, Conget I, Olsen B, Schutz-Fuhrmann I, Hommel E, Hoogma R . The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012; 55(12):3155-62. PMC: 3483098. DOI: 10.1007/s00125-012-2708-9. View